Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet — FDA Drug Shortage
The FDA lists a drug shortage record for Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet (tablet) from Oryza Pharmaceuticals Inc. with status Current. The shortage was first posted on Oct 12, 2022. Reported reason: Shortage of an active ingredient
Shortage details
- Status
- Current
- Company
- Oryza Pharmaceuticals Inc.
- Package NDC
- 72516-012-01
- Dosage Form
- Tablet
- Presentation
- Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 72516-012-01)
- Initial Posting
- Oct 12, 2022
Reason
Shortage of an active ingredient